Joseph Ciaffoni

Joseph Ciaffoni

Chief Executive Officer at
Indivior Ltd.

Net worth: 32 M $ as of 30/06/2026

55 year
Health Technology
Consumer Services

Profile

Mr. Joseph J.
Ciaffoni
is a Chief Executive Officer & Director at Indivior Pharmaceuticals, Inc. and a Chief Executive Officer & Director at Indivior Ltd. He is on the Board of Directors at Indivior Pharmaceuticals, Inc. and Indivior Ltd. Mr. Ciaffoni was previously employed as a President & Chief Executive Officer by BioDelivery Sciences International, Inc., a President & Chief Executive Officer by Collegium Pharmaceutical, Inc., a President-US Branded Pharmaceuticals by Endo International Plc, a Senior VP-Global Specialty Medicines Group by Biogen-Idec Pharmaceuticals, Inc., a Chief Commercial Officer & Executive VP by Shionogi Pharma, Inc., a Chief Operating Officer & Executive VP by Shionogi, Inc., and a Vice President-Sales by Schering-Plough Corp.
He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Rutgers State University of New Jersey.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.65%
22/06/2026 790,330 ( 0.65% ) 32 M $ 30/06/2026

Joseph Ciaffoni active positions

CompaniesPositionStart
Chief Executive Officer -

Former positions of Joseph Ciaffoni

CompaniesPositionEnd
COLLEGIUM PHARMACEUTICAL, INC. Chief Executive Officer 24/05/2024
ENDO INTERNATIONAL PLC Corporate Officer/Principal 01/12/2016
Corporate Officer/Principal 01/07/2016
Corporate Officer/Principal 01/10/2010
Chief Operating Officer 01/10/2010
See the detail of Joseph Ciaffoni's experience

Training of Joseph Ciaffoni

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

82

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Joseph Ciaffoni